What if diagnosing coronary artery disease, pulmonary hypertension, and heart failure didn't require a hospital, a specialist, or even invasive testing?

In this episode, Adrian Lam, CEO of Corvista Health, shares how their FDA-cleared, AI-powered platform is transforming frontline cardiac care—delivering accurate, non-invasive diagnostics in under 30 minutes. Adrian discusses the delicate balance of explainable AI, clinical trust, and business strategy. He also dives into lessons on IP protection, clinical validation, and why understanding unmet needs—both clinical and operational—is key to commercial success.

From rural health access to drug monitoring and phenotypic insights, this episode is packed with lessons for medtech entrepreneurs, investors, and innovators alike.